Faculty profile

Paul Toren

ResearcherSurgeryUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.

Paul Toren

Researcher

Surgery

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
33 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

5-Alpha Reductase Inhibitors Clinical Trial Development Non-Muscle Invasive Bladder Cancer Tumor Recurrence Urology Anti-Androgens Bacille-Calmette Guérin Therapy Bladder Cancer

Latest papers

Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis.
International urology and nephrology · 2026
Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer Real-world data from 50 consecutive cases treated in a single Canadian center.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.
BMJ open · 2026

All 56 publications

Latest funding

Repurposing 5-alpha reductase inhibitors to improve outcomes for bladder cancer patients
CIHR · 2025 · Nominated PI
$994,500
Targeting sex steroids to improve the response to bladder cancer immunotherapy
CIHR · 2021 · Nominated PI
$822,376
Towards optimization of anti-hormonal therapy in advanced prostate cancer
CIHR · 2019 · Co-investigator
$765,000

All 3 grants and awards

56 publications.

Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis.

Suartz CV, Costa MSS, Matalani CFA, da Rocha MR, Micheleto JPC, Furlam PL, Lepine HL, Lopes RI, Talizin TB, Júnior JB, Shahrour W, Shabana W, Merseburger AS, Reis LO, Cordeiro MD, Nahas WC, Toren P, Ribeiro-Filho LA, Ploussard G, Fradet V, Pouliot F

International urology and nephrology2026

DOI: 10.1007/s11255-026-05182-5 PMID: 42230439

Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer Real-world data from 50 consecutive cases treated in a single Canadian center.

Pouliot F, Lodde M, Besançon M, Castonguay V, Morin-Coulombe A, Fradet V, Fradet Y, Lacombe L, Lévesque É, Marcoux N, Toren P, April G, Arsenault F, Beaulieu A, Singbo N, Veilleux C, Tremblay-Boily M, Tremblay V, Buteau FA, Beauregard JM

Canadian Urological Association journal = Journal de l'Association des urologues du Canada2026

DOI: 10.5489/cuaj.9398 PMID: 41701883

Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.

Moussa H, Tourigny R, Robitaille K, Bussières V, Fadel J, Ben Souilah F, Diabaté L, Hovington H, Bettan L, Lacombe L, Dujardin T, Lodde M, Toren P, Aprikian A, Saad F, Carmel M, Jeldres C, Lamarche B, Bergeron A, Fradet Y, Fradet V, Network BIOCaPPE

BMJ open2026

DOI: 10.1136/bmjopen-2025-111118 PMID: 42209010

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Müller DC, Murtha AJ, Bacon JVW, Stephenson M, Wells C, Vasquez-Rios C, Rostin K, Rebane L, Schönlau E, Nikkola J, Alimohamed N, Basappa NS, Finch D, Ko JJ, Lavoie JM, Nappi L, Noonan K, Ong M, Ozgun G, Parimi S, Soleimani M, Sridhar SS, Toren P, Winquist E, Bernales CQ, Koudjanian M, Atwal J, Fung E, Khan L, Eigl B, Othman D, Bismar TA, Wang G, Merza R, Papadakis AI, Spatz A, Kollmannsberger C, Maurice-Dror C, Annala M, Chi KN, Vandekerkhove G, Wyatt AW, Eigl BJ

Nature communications2026

DOI: 10.1038/s41467-026-69927-7 PMID: 41760649

Development of a reoperative risk prediction model of muscle-invasive upper tract urothelial carcinoma using clinical and radiomic computed tomography features: Initial results from a multi-institutional Canadian study.

Nguyen DD, Nasute Fauerbach PV, Kwong JCC, McLoughlin L, Lajkosz K, Al-Rumayyan M, Alam A, Fugaru I, St-Laurent MP, Toren P, Fradet V, Rendon RA, Siemens DR, Breau RH, Kassouf W, Black PC, Kulkarni GS, Haider MA

Canadian Urological Association journal = Journal de l'Association des urologues du Canada2025

DOI: 10.5489/cuaj.9370 PMID: 41406346

The efficacy and safety of tranexamic acid use during radical cystectomy: A systematic review and meta-analysis.

Suartz CV, Lepine HL, Matalani CFA, Parente MPEA, Moura DS, Zollinger LBC, Lopes RI, Júnior JB, Cordeiro MD, Reis LO, Chun JTY, Motta JM, Nahas WC, Toren P, Ribeiro-Filho LA

Canadian Urological Association journal = Journal de l'Association des urologues du Canada2025

DOI: 10.5489/cuaj.9266 PMID: 41061691

Neoadjuvant Immunotherapy in Bladder Cancer: Ushering in a New Era of Treatment-A Systematic Review of Current Evidence.

Suartz CV, de Lima RD, de Almeida LS, Liebl B, Lopes RI, Branquinho Reis GB, Henry Sant'Anna PV, Faris de Campos VD, Mota JM, Lima Aguiar Melão BV, Nahas WC, Shahrour W, Shabana W, Ribeiro-Filho LA, Toren P, Fradet V

European urology open science2025

DOI: 10.1016/j.euros.2025.07.010 PMID: 40822997

Urachal Carcinomas: A Comprehensive Systematic Review and Meta-analysis.

Suartz CV, Martinez LM, Silvestre MHL, Lima RD, Brito PHS, Galhardo KA, Lopes RI, Moraes VHS, Moraes CMT, Covatti L, Azevedo MFD, Almeida LS, Setoue DND, Braz NDSF, Bessa J, Korkes F, Reis LO, Leite KRM, Nahas WC, Toren P, Ribeiro-Filho LA

International braz j urol : official journal of the Brazilian Society of Urology2025

DOI: 10.1590/s1677-5538.ibju.2024.0665 PMID: 39908206

Comparing open and video endoscopic lymphadenectomy for penile cancer: a systematic review and meta-analysis of prospective studies.

Suartz CV, de Lima RD, Abud LR, Brito PHS, Galhardo KA, Talizin TB, Salazar AL, Korkes F, Guglielmetti G, de Cássio Zequi S, Ribeiro-Filho LA, Toren P, Lodde M

BJU international2025

DOI: 10.1111/bju.16661 PMID: 39856798

Reevaluating the Role of Extended Pelvic Lymphadenectomy in Muscle-Invasive Bladder Cancer: Insights From SWOG S1011 and LEA AB 25-02 Trials.

Suartz CV, Fradet V, Toren P, Ribeiro-Filho LA, Chade D, Korkes F

Clinical genitourinary cancer2025

DOI: 10.1016/j.clgc.2024.102249 PMID: 39580935

Something wrong or missing on this profile? Suggest a correction

Paul Toren

Research

Latest papers

Latest funding

Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis.

Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer Real-world data from 50 consecutive cases treated in a single Canadian center.

Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Development of a reoperative risk prediction model of muscle-invasive upper tract urothelial carcinoma using clinical and radiomic computed tomography features: Initial results from a multi-institutional Canadian study.

The efficacy and safety of tranexamic acid use during radical cystectomy: A systematic review and meta-analysis.

Neoadjuvant Immunotherapy in Bladder Cancer: Ushering in a New Era of Treatment-A Systematic Review of Current Evidence.

Urachal Carcinomas: A Comprehensive Systematic Review and Meta-analysis.

Comparing open and video endoscopic lymphadenectomy for penile cancer: a systematic review and meta-analysis of prospective studies.

Reevaluating the Role of Extended Pelvic Lymphadenectomy in Muscle-Invasive Bladder Cancer: Insights From SWOG S1011 and LEA AB 25-02 Trials.

Repurposing 5-alpha reductase inhibitors to improve outcomes for bladder cancer patients

Targeting sex steroids to improve the response to bladder cancer immunotherapy

Towards optimization of anti-hormonal therapy in advanced prostate cancer

Frequent collaborators

Vincent Fradet

Chantal Guillemette

Jean-Mathieu Beauregard

Wassim Kassouf

Rachid Mazroui

Alexandre Zlotta

Marie-Pier St-Laurent

Gang Wang

Michael Ong

Martin Pelletier

Dirk Lange

Caroline Diorio

Isabelle Gaboury

Caroline Gilbert

Amina Zoubeidi

Étienne Audet-Walsh

Madhuri Koti

Neil Fleshner

Jean-Philippe Lambert

Eric Winquist

Benoît Lamarche

Lucia Nappi

Steve Bilodeau

Catherine Hudon

Arnaud Droit